A novel PET (positron emission tomography) tracer for donut-like PET findings in patients with neuroendocrine tumours

Recruiting

• Conditions: euroendocrine tumours; Neuroendocrine tumours; Cancer - Neuroendocrine tumour (NET)

• Registration Number: ACTRN12618001819213
• Lead Sponsor: orthern Sydney Local Health District

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-11-08
• Last Update Posted: 19 November 2018

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 10

Inclusion Criteria

1) Patients 18 years of age or older with metastatic neuroendocrine neoplasm (NEN) and histological confirmation who have undergone PET scans at Royal North Shore Hospital
2) Patients identified by the nuclear medicine physicians as having a lesion with 68Ga-DOTATATE PET (DOTA) avidity on the periphery but not the centre of the lesion (i.e. lack of avidity in the hole of the donut-like tumour).

Exclusion Criteria

1) Patients who have not received a PET scan at RNSH
2) Patients without a histological diagnosis of metastatic NEN
3) Inability to lie in a supine position on the PET scanning bed for 15 minutes;
4) Subjects who required sedation for their baseline clinical PET scan;
5) Renal failure requiring haemo- or peritoneal dialysis;
6) Substance abuse, medical, psychological or social conditions that in the opinion of the investigator may interfere with the patient’s participation in the study or evaluation of the study results;

Study & Design

• Study Type: Interventional
• Study Design: Not specified